ECS
ECSBOTANIC FPO [ECS]
Healthcare · ASX Small Cap
$0.0060 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +5First seen: 2026-02-25
Score Breakdown
Technical45
Catalyst54
Sentiment50
Fundamental39
Momentum52
Risk Gate20
Active Signals
Bullish Signals
- VPT accumulation divergence (bullish)
- Critical cash runway (0.3 quarters)
- Low P/S ratio (0.5x)
- Moderate revenue growth (+10%)
- Near 52-week low (14% of range)
- Micro-cap ($5-20M) - high risk
- CANSLIM A: Turned profitable
- Altman Z-Score in distress zone (0.77 < 1.81)
- Penny stock risk ($0.006)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (2/9)
- Deeply negative margins (-30%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-40%)
Recent Catalysts
NONE H1 FY26 Results-Return to Profitability & Positive Cashflow
NONE Half Yearly Report and Accounts
NONE Security Class Reinstatement to Quotation - ECSO
MEDIUM ECS Enters German Distribution Partnership with OzSun
Announcement tone +3pts
Recent ASX Announcements
| 2026-02-27 | H1 FY26 Results-Return to Profitability & Positive Cashflow PRICE SENSITIVE |
| 2026-02-27 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-10 | ECS Enters German Distribution Partnership with OzSun PRICE SENSITIVE |
| 2026-01-30 | Security Class Reinstatement to Quotation - ECSO PRICE SENSITIVE |
| 2026-01-30 | Change of Director's Interest Notice (X2) |
Key Metrics
$9.6M
Market Cap
2.6M
Avg Volume
1.3x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-22.6%
ROE
-29.6%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 50% |
| L | Leader vs Laggard | pass | RS: 2 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #86 of 119 · Sector avg: 51
View all Healthcare signals →